Skip to main content

Table 3 Relative expression levels of RBM6 in chimeric positive versus chimeric negative tumour samples compared to non-tumour

From: RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours

  RBM6 (mean ± SD) Control (S28) (mean ± SD) normalized RBM6 fold change in tumour compared to non-tumour
Breast Tissue     
tumour     
   chimeric transcript (+) 0.403 ± 0.008 0.073 ± 0.007 5.521 24.43
   chimeric transcript (-) 0.243 ± 0.012 0.066 ± 0.01 3.682 16.3
non-tumour 0.051 ± 0.006 0.226 ± 0.06 0.226 1
Skeletal Muscle     
tumour: chimeric transcript (+) 0.0488 ± 0.001 0.0489 ± 0.005 0.998 14.06
non-tumour 0.005 ± 0.0003 0.070 ± 0.01 0.071 1
tumour: chimeric transcript (-) 0.063 ± 0.01 0.297 ± 0.058 0.212 1.52
non-tumour 0.022 ± 0.002 0.158 ± 0.02 0.139 1
  1. (+) : chimeric transcript positive, (-) : chimeric transcript negative.